Long-term success often depends on finding the minimum effective dose rather than staying at the maximum
We're excited to bring this powerful tool to many more clients struggling with their weight change goals
Reduced appetite while therapeutically intended, this can occasionally lead to inadequate nutritional intake Injection site reactions mild redness, bruising, or discomfort at the site of subcutaneous injection Fatigue and dizziness reported in a subset of trial participants, often associated with early treatment phases Hypoglycaemia (low blood sugar) uncommon with retatrutide alone, but the risk increases when it is used alongside insulin or sulfonylureas
Yes, it does matter where you inject semaglutide
If you have Type 2 diabetes with obesity, cardiovascular disease, kidney disease, or simply inadequate control on current medications, GLP-1 treatment deserves serious consideration